Noh Joseph J, Kim Myeong-Seon, Lee Yoo-Young
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Gland Surg. 2021 Mar;10(3):1182-1194. doi: 10.21037/gs.2020.04.07.
The enhanced recovery after surgery (ERAS) refers to multimodal interventions to reduce the length of hospital stay and complications at various steps of perioperative care. It was first developed in colorectal surgery and later embraced by other surgical disciplines including gynecologic oncology. The ERAS Society recently published guidelines for gynecologic cancer surgeries to enhance patient recovery. However, limitations exist in the implementation of the guidelines in ovarian cancer patients due to the distinct characteristics of the disease. In the present review, we discuss the results that have been published in the literature to date regarding the ERAS protocols in ovarian cancer patients, and explain why more evidence needs to be specifically assessed in this type of malignancy among other gynecologic cancers.
术后加速康复（ERAS）是指在围手术期护理的各个阶段采取多模式干预措施，以缩短住院时间并减少并发症。它最初是在结直肠手术中发展起来的，后来被包括妇科肿瘤学在内的其他外科学科所采用。ERAS学会最近发布了妇科癌症手术指南，以促进患者康复。然而，由于卵巢癌疾病的独特特征，这些指南在卵巢癌患者中的实施存在局限性。在本综述中，我们讨论了迄今为止文献中发表的关于卵巢癌患者ERAS方案的结果，并解释了为什么在这种恶性肿瘤以及其他妇科癌症中需要专门评估更多证据。
